http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2011000589-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2011-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e679b6af42bc00fd40a36fc9d2229c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7bb2dd686f1609e2816c7c2c125ee62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0abd2ff28f9d5280750e89ab0e196ce3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e16aeb51dd14021dccb06e6ede4f102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c55066547cf34dce3f7b3d4850bffc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c616320db2c9d12f9af9947557c1e8d
publicationDate 2011-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2011000589-A1
titleOfInvention Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer.
abstract THE PRESENT INVENTION DISCLOSES COMPOUNDS OF THE FORMULA (I): WHERE X, Y, R1, R2, R3, R4, R5, R6 AND R7 HAVE THE MEANINGS DESCRIBED IN THE DISCLOSURE OF CLAIMS; THE PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME; PHARMACEUTICAL COMPOSITION INCLUDING SUCH COMPOUNDS, AND THE USE OF SUCH COMPOSITION AND COMPOUNDS IN THE TREATMENT OF CANCER.
priorityDate 2008-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421069037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID550774

Total number of triples: 37.